Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Safety and Efficacy of Abemaciclib Plus Endocrine Therapy in Older Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: An Age-Specific Subgroup Analysis of MONARCH 2 and 3 TrialsBreast Cancer Res Treat 2021 Jan 03;[EPub Ahead of Print], MP Goetz, M Okera, H Wildiers, M Campone, EM Grischke, L Manso, VAM André, N Chouaki, B San Antonio, M Toi, GW Sledge
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.